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Abstract  
Left ventricular (LV) mass and volume are important indicators of clinical and pre-
clinical disease processes. However, much of the shape information present in modern 
imaging examinations is currently ignored. Morphometric atlases enable precise 
quantification of shape and function, but there has been no objective comparison of 
different atlases in the same cohort. We compared two independent LV atlases using 
MRI scans of 4547 UK Biobank participants: i) a volume atlas derived by automatic 
non-rigid registration of image volumes to a common template, and ii) a surface atlas 
derived from manually drawn epicardial and endocardial surface contours. The 
strength of associations between atlas principal components and cardiovascular risk 
factors (smoking, diabetes, high blood pressure, high cholesterol and angina) were 
quantified with logistic regression models and five-fold cross validation, using area 
under the ROC curve (AUC) and Akaike Information Criterion (AIC) metrics. Both 
atlases exhibited similar principal components, showed similar relationships with risk 
factors, and had stronger associations (higher AUC and lower AIC) than a reference 
model based on LV mass and volume, for all risk factors (DeLong p<0.05). 
Morphometric variations associated with each risk factor could be quantified and 
visualized and were similar between atlases. UK Biobank LV shape atlases are robust 
to construction method and show stronger relationships with cardiovascular risk factors 
than mass and volume.  
Keywords: ventricular function, atlases, cardiovascular risk factors, UK Biobank. 
 
  
  
                  
Introduction 
Left ventricular (LV) morphology and function is important for the evaluation of 
cardiovascular disease. Changes in shape, known as remodeling, can manifest as 
changes in LV mass, volume, sphericity, wall thickness, and other shape indices, due 
to clinical and pre-clinical disease processes. Previous studies have shown the 
importance of remodeling in the evaluation of 10-year survival rates after a myocardial 
infarction 1-3. Pre-clinical remodeling also occurs in asymptomatic individuals prior to 
the establishment of clinical disease, in response to exposure to risk factors and 
genetic interactions 4. However, current shape measures of LV mass and volume 
ignore most of the shape information available in modern medical imaging 
examinations. The UK Biobank employed cardiac magnetic resonance (CMR) imaging 
to examine the pre-clinical determinants of cardiac disease 5,6. This large-scale cohort 
study has enabled investigation of reference characteristics in healthy participants 7, 
and mechanistic relationships with cardiovascular risk factors 8. 
Atlases of the LV have recently been employed to produce statistical shape models, 
giving highly detailed morphometric information in a standardized coordinate space, 
suitable for large cohort studies 9-11. Compared with the American Heart Association 
17-myocardial segment model 12, atlas-based analyses represent morphology at high 
spatial resolution, enabling quantification of multidimensional statistical information at 
each point in the atlas 13. Changes in LV morphometry have been demonstrated in 
healthy adults who were born prematurely 14, volunteers with titin-truncating variants 
15, genetic mutations affecting LV mass 16, higher fat mass 17, higher blood pressure 
13, and smoking and other risk factors in the Multi-Ethnic Study of Atherosclerosis 
(MESA) 9. Atlas based methods have also been used to quantify remodeling patterns 
in patients with myocardial infarction 18, shape features associated with response after 
                  
cardiac resynchronization therapy 19, and impairment of function in congenital heart 
disease 20. 
However, atlas-based shape measures may be influenced by the methods used in their 
construction, and this may affect the resulting shape analyses. Two different types of 
atlas have been derived to date, using either volume image registration 10,13,15-17 or 
surface registration 9,14,18-20 methods. The key difference between these approaches is 
in the non-rigid registration techniques used to map the anatomy of each patient’s heart 
into a common coordinate system. Volumetric image registration methods utilize image 
intensity features to compute the mapping of each case onto the common space. 
Conversely, surface registration methods use knowledge of the boundaries of the heart 
in the registration process. Each type of atlas may therefore result in different LV shape 
characteristics. To date, there has been no objective comparison of different types of 
atlas in the same cohort.  
Here, we describe the construction of two types of atlas, derived using volume and 
surface registration methods respectively, from 4,547 participants of the CMR 
extension to UK Biobank. By comparing morphometric indices between atlases, we 
investigated the extent to which results were dependent on the method used to 
construct the atlas. We also examined whether the shape atlases provided stronger 
relationships with known cardiovascular risk factors, in comparison with the standard 
indices of LV mass and volume. We also compared morphometric risk factor scores 
and morphometric shape variations from both atlases to characterize the associations 
between LV shape and cardiovascular risk factors. 
                  
 
Results 
Of the first 5,065 CMR UK Biobank imaging extension participants, 4,547 common 
cases could be used to construct volume and surface atlases. The remaining 518 
cases had missing information required for one or other of the atlases (either missing 
images or contours). Table 1 shows the participant characteristics. The surface atlas 
construction process is shown in Figure 1, and the volume atlas construction process 
is shown in Figure 2. Of the 4,547 cases in both atlases, 751 were identified in the 
reference healthy cohort with no risk factors 7. 
Figure 3 shows the first three principal component shape modes describing the most 
variation in the cohort, for the surface atlas at both end-diastole (ED) and end-systole 
(ES). The graphs show the cumulative amount of variance explained by each principal 
component mode for the first 20 modes in each atlas. In the surface atlas, the first 
principal component (explaining over 40% of the total variance) was associated with 
LV size for both ED and ES. The second principal component was associated with LV 
height to width ratio, or sphericity. The third principal component was associated with 
the mitral valve plane orientation.  
Figure 4 shows the first three principal component shape modes of the volume atlas, 
together with graphs of cumulative percentage variance explained for the first 20 
modes. Similar to the surface atlas, the first principal component was associated with 
LV size, the second with sphericity and the third with mitral valve plane orientation. 
Each mode explained a similar proportion of the total variance as the corresponding 
surface atlas mode.  
                  
Table 2 shows the strength of relationships between the risk factors and shape, using 
logistic regression analysis with five-fold cross validation. Each risk factor was treated 
as the dependent variable in the logistic regression analysis, with 1 for participants 
positive for the risk factor and 0 for the participants in the reference healthy cohort with 
no risk factors 7. For each analysis, the first 20 scores from the ED principal component 
analysis and the first 20 scores from the ES principal component analysis were used 
as independent variables. For comparison, a similar logistic regression cross-validation 
analysis was also performed using the traditional measures of LV mass, ED and ES 
volume as the independent variables (termed “MassVol” in Table 2). Both volume and 
surface atlases gave stronger associations, i.e. larger AUC and lower AIC, between 
LV shape and all risk factors, compared to the MassVol model. Similar AUC (DeLong 
p=NS) and AIC values were found between the surface and volume atlases. Figure 5 
shows the AUC for each risk factor as the number of principal component modes was 
increased from 1 to 50. Approximately three ED and ES modes were needed for the 
atlases to achieve comparable performance to the MassVol model. Performance was 
stable after about 7 modes.  
Morphometric risk factor scores were calculated over the whole cohort using the 
logistic regression coefficients to combine component scores into a single z-score for 
each risk factor. Similar score distributions were found for the volume and surface 
atlases. Figure 5 shows density plots for the morphometric risk factor score associated 
with the risk factors. In each plot two patient groups are shown with the reference 
cohort (blue) and the risk factor positive cohort (orange). Both atlases had higher 
separation of scores between groups than those derived from the MassVol model for 
all risk factors.  Figure 6 shows the 5th and 95th percentiles of the morphometric shape 
variation associated with each factor. The figure shows the variation in shape, as 
                  
weighted by the model regression coefficients. Angina was associated with an overall 
outward displacement at ED. Diabetes was associated with a bulging at the apex. High 
blood pressure, high cholesterol, and smoking were associated with a septal outward 
displacement toward the apex but inward near the base. 
 
Discussion 
The results of this study indicate that LV shape atlases show consistent relationships 
with cardiovascular risk factors, irrespective of the methodology used to derive the 
atlas. Two types of atlas were constructed from the same cohort of CMR examinations, 
performed as part of the UK Biobank imaging extension. The two atlases used different 
methods to calculate shape characteristics, the volume atlas being based on intensity 
differences in the MRI cine images, and the surface atlas being based on manual 
contours drawn on the epicardial and endocardial surfaces. However, both had similar 
principal component shape modes, similar principal components, and similar 
associations with cardiovascular risk factors. These associations were stronger than 
those with standard measures of LV mass and volume, in both atlases. These results 
suggest that shape features derived from these atlases are not severely impacted by 
methodology, but express real anatomical characteristics related to cardiovascular risk 
factors. 
In a previous LV surface atlas study from other asymptomatic cohort (the Multi-Study 
of Atherosclerosis or MESA)9, we found similar shape modes. The shape mode 
explaining the most variation (first principal shape mode) was associated with LV size 
in both volume and surface atlases, as well as in the MESA atlas. The second principal 
                  
shape mode, orthogonal to the first, describes LV sphericity in both UK Biobank 
atlases, and also in the MESA atlas 9. Both LV size and sphericity are known to be 
associated with adverse events in patients with clinical disease and in largely healthy 
populations 1-4.  
Both atlases had stronger associations with risk factors than traditional measures of 
LV morphometry (mass and volumes).  Similar associations were found between 
shape and risk factors regardless of atlas construction. In addition to providing 
information on the morphological changes associated with risk factors, these atlases 
can also be used to evaluate individual patients during longitudinal follow-up. For 
example, z-scores could be calculated for each visit, indicating where the patient ranks 
in relation to the UK Biobank population. A change in z-score towards the positive end 
would indicate a deterioration in LV shape over time.  Morphometric risk factor scores 
can then be included in future studies of outcomes over time, for example in Cox 
models along with sex, body mass index and age, in comparison to the risk factors 
themselves. 
Limitations of this study include the cross-sectional nature of the UK Biobank; however, 
as events are recorded into the future, it may be possible to determine the extent to 
which LV shape features can add to prediction of future events. Also, neither 
cholesterol nor glucose blood test data was available at the time of writing. Risk factors 
were self-reported and may suffer from subjective bias. Since the intention of the 
current study was to compare shape atlases, we did not correct shape scores for sex, 
age, body mass index, etc. In the future, these atlases could be used in conjunction 
with other factors in multivariate models to better understand shape changes in more 
targeted groups, such as those with different environmental or haemodynamic factors. 
Finally, the surface approach requires initial segmentation of the LV contours and 
                  
landmarks; however, machine learning methods show promise to automatically 
provide these data 21.   
Conclusions  
Both volume and surface cardiac atlases show similar morphometric characteristics, 
suggesting that shape scores derived from LV atlases are robust and quantify real 
anatomical relationships with cardiovascular risk factors. Morphometric scores are 
more sensitive to detect differences in LV shape associated with cardiovascular risk 
factors than traditional measures of mass and volume.  
Methods 
Study Population 
The UK Biobank has collected questionnaire data, physical measurements and 
biological samples from 500,000 individuals in the UK 22. The imaging extension aims 
to obtain brain, heart, whole body composition, carotid artery, bone and joint imaging 
in 100,000 participants by 2022. Here, we assessed CMR examinations from the first 
5,065 UK Biobank imaging extension participants. All participants gave written 
informed consent and the appropriate institutional review boards approved the study 
protocol (National Research Ethics Service North West 11/NW/0382). All research was 
performed in accordance with the relevant guidelines and regulations.  
Similar to a recent analysis of relationships between cardiovascular risk factors and LV 
mass and volume in the same cohort 8, we investigated the associations between 
multidimensional LV shape derived from the atlases, and each of the following risk 
factors: high blood pressure, smoking, diabetes, high cholesterol, and angina. High 
blood pressure, diabetes, high cholesterol and angina were taken from self-reported 
                  
vascular/heart or non-cancer conditions or problems diagnosed by physician. Smoking 
was taken as current tobacco smokers. Participants positive for each risk factor were 
compared with a reference healthy cohort defined according to the criteria described 
in 7. The reference cohort excluded all participants with known cardiovascular disease, 
hypertension, respiratory disease, diabetes, hyperlipidaemia, haematological disease, 
renal disease, rheumatological disease, malignancy, symptoms of chest pain or 
dyspnoea, age over 74 years old, current- or ex-tobacco smokers, those taking 
medication for diabetes, hyperlipidaemia or hypertension and those with BMI ≥30 
kg/m2.  
Imaging Protocol 
The CMR protocol has been described in detail previously 23. Briefly, all imaging was 
performed on a wide bore 1.5T scanner (MAGNETOM Aera, syngo MR D13A, 
Siemens Healthineers, Erlangen, Germany) using a phased-array cardiac coil. 
Retrospectively gated cine balanced steady-state free precession breath-hold 
acquisitions were performed in horizontal long axis, vertical long axis, left ventricular 
outflow tract orientations, and a short axis stack covering the left and right ventricles. 
Typical parameters were: TR/TE=2.6/1.1ms, flip angle 80°, GRAPPA factor 2, voxel 
size 1.8 x 1.8 x 8 mm³ (6 mm for long axis). The actual temporal resolution of 32 ms 
was interpolated to 50 phases per cardiac cycle (~20 ms). No signal or image filtering 
was applied besides distortion correction. 
Manual Analysis 
The manual contouring process was performed in accordance with the Society of 
Cardiovascular Magnetic Resonance recommendations, as described in detail 
previously 7. Briefly, short axis images were contoured at end-diastole (ED) and end-
                  
systole (ES) using cvi42 post-processing software (Version 5.1.1, Circle Cardiovascular 
Imaging Inc., Calgary, Canada), by eight readers in two core laboratories. The ED 
frame was selected as the first frame after detection of the R wave, and the ES frame 
was selected as the smallest LV blood pool area in the mid-ventricular slice. At both 
ED and ES, the most basal slice included had at least 50% of the LV blood pool 
surrounded by myocardium. Papillary muscles were included in the blood pool. Left 
atrial contours delineated on the two chamber and four chamber long axis slices, and 
right ventricular contours on the short axis slices, were also used in this study to 
delineate the extent of the LV and the location of the interventricular septum. 
Interobserver agreement in mass and volume estimates was excellent, with intra-class 
correlation coefficients of 0.88 and above 7. 
Surface Atlas 
The surface atlas was constructed using the method described by Medrano-Gracia et 
al. 9. Briefly, a finite element shape model was fitted to the manual contours by least 
squares optimization. The extent of the LV was defined from landmarks on mitral valve 
(derived from the extent of the left atrium contour) and a LV apex point obtained from 
the cvi42 contour files. The septum was located using the insertions of the RV contour 
with the LV contour (calculated from the RV endocardial contour). After orienting the 
model according to the landmarks, the endocardial and epicardial surfaces were fitted 
to the landmarks and short axis contours by minimizing the distance between the 
surfaces and the contour points. Mis-registrations of the contours due to differences in 
the breath-hold position from slice to slice were automatically corrected by shifting the 
contours in-plane to match an initial stiff model fit 9. Figure 1 illustrates the formation 
of the resulting atlas.  
                  
Volume Atlas 
The volume atlas was constructed using the method described by Bai et al. 10. Briefly, 
a common template image space and myocardial mesh were used, which were 
previously derived from high-resolution 3D MR images [8]. Each short axis image stack 
was first corrected for breath-hold mis-registration using the same method as for the 
surface atlas construction. Each corrected image volume was then registered to the 
template space 10 using non-rigid B-spline image registration 24. For each case, the 
displacement field was stored to give a mapping from subject space to template space 
at each voxel. The template mesh was propagated to each subject using the inverse 
displacement map. Each subject mesh then had the same number of vertices as the 
template mesh. Figure 2 shows the construction of the resulting atlas.  
Statistics 
For each atlas, two statistical shape models were generated, one at ED and the other 
at ES, using principal component analysis. This procedure calculated the principal 
modes of shape variation across the cohort, ordered by amount of variance explained 
11. Firstly, point clouds were generated on the epicardial and endocardial surfaces of 
the finite element model, or from the volume atlas myocardial mesh. Within each 
statistical shape model, the point clouds were aligned using the Procrustes method 25, 
without scale correction (i.e. translation and rotation alignment only). Principal 
component shape modes were then calculated at ED and ES as described previously 
9,10. Each case could then be represented by a set of principal component scores, 
which represent the amount of each mode present in that case.  
Associations between LV shape and risk factors were examined using logistic 
regression linear models. For each risk factor, a separate linear model was generated 
                  
using that factor as a binary univariate dependent variable, and the principal 
component scores as the independent variables. The strength of the association 
between shape and risk factor was quantified using two metrics: i) the area under the 
curve of the receiver operating characteristic (AUC) and ii) the Akaike information 
criterion (AIC). The AUC is a measure of the overall performance of the logistic 
regression model and reflects the probability of correctly ranking any pair of 
positive/negative cases 26. A value closer to 1.0 is indicative of a better model. The AIC 
is a measure of relative quality of the model, with lower values indicating better 
goodness of fit corrected for the independent variables 27. To prevent overfitting, a five-
fold cross validation scheme was employed in which the dataset was randomly divided 
into five groups, and the model trained on 4/5 and tested on the remaining 1/5 for each 
of the five groups. For comparison, logistic regression cross-validation models were 
also formed using ED volume, ES volume and LV mass as the independent variables, 
and the strengths of association compared with the shape atlases. Significant 
improvements in AUC were tested using DeLong’s test 28.  
Morphometric risk factor scores were derived from the logistic regression coefficients 
obtained for each risk factor, as follows. The logistic regression coefficients represent 
a linear combination of principal shape modes which best describe differences 
between the reference cohort and the risk factor positive participants. Therefore, a 
combined score was calculated by multiplying each principal component score by its 
corresponding logistic regression weight and summing over components. These 
scores were calculated for all participants and normalized into z-scores. These scores 
provide a simple way of quantifying shape characteristics for each case in relation to 
the population. Similarly, a morphometric risk factor shape variation could be 
calculated to visualize the shape change associated with the morphometric score. 
                  
Statistical analysis was performed using R (version 3.3.0) Statistical Software 29 and 
the caret package 30.  
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Figure 1. Surface atlas construction. Left to right: Images to average shape model. 
 
 
Figure 2 Volume atlas construction. Left to right: Images to shape model. 
 
                  
 
 
Figure 3 Principal component analysis results for the surface atlas. a) ED first three 
principal components; b) ES first three principal components; c) ED % variance 
explained for the first 20 modes; d) ES % variance explained for the first 20 modes. 
The viewpoint is from the septum with the inferior wall on the left.  
                  
 
Figure 4. Principal component analysis results for the volume atlas. a) ED first three 
principal components; b) ES first three principal components; c) ED % variance 
explained for the first 20 modes; d) ES % variance explained for the first 20 modes. 
The viewpoint is from the septum with the inferior wall on the left. 
 
 
                  
 
Figure 5. Cumulative area under the curve with increasing numbers of modes 
included and density of morphometric risk factor scores. Scores for the reference 
(healthy) cohort are shown in blue  and those for risk factor positive cases are shown 
in orange.  
 
  
                  
 
Figure 6. Morphometric risk factor shapes. The 9th and 95th percentile of the logistic 
regression models rendered at ED and ES. The average shapes were drawn with 
differences shown in the color scale yellow (outward surface movement) to blue 
(inward surface movement). View point is from the anterior, with septum on the left. 
Displacements are in mm 
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Table 1. Participant characteristics for those cases in both atlases (n=4547). Values 
are given as mean ± standard deviation for continuous variables, and count (%) for 
categorical variables.  
 
  
Age (years) 62 ± 8 
Sex (male) 2153 (47%) 
Height (cm) 170 ± 9 
Weight (kg) 76 ± 15 
Body surface area (m2) 1.85 ± 0.21 
Systolic blood pressure (mmHg) 139 ± 19 
Diastolic blood pressure (mmHg) 79 ± 11 
Heart Rate (bpm) 68 ± 11 
High blood pressure 1183 (26%) 
Smoking (never) 2688 (59%) 
Smoking (previous) 1552 (34%) 
Smoking (current) 296 (7%) 
Diabetes 235 (5%) 
Angina 104 (2%) 
Asthma 493 (11%) 
High Cholesterol 1183 (26%) 
 
 
 
  
                  
Table 2 Five-fold cross-validated logistic regression analysis results for binomial 
categorical factors and LV shape (first 20 principal component modes from ED and 
ES). MassVol model includes LV mass, EDV and ESV as independent variables. 
Each cell has AUC (AIC). *P<0.05, **P<0.01, ***P<0.001, DeLong’s test for 
differences in AUC from MassVol AUC.   
 
 Volume Atlas Surface Atlas MassVol 
High blood pressure  0.77*** (2157) 0.76*** (2143) 0.68 (2382) 
Smoking  0.68* (1174) 0.68* (1156) 0.62 (1213) 
Diabetes 0.80*** (857) 0.79*** (869) 0.70 (1001) 
High cholesterol 0.73** (1124) 0.73** (1126) 0.65 (1224) 
Angina  0.77* (551) 0.76* (528) 0.67 (607) 
 
 
 
